Indfrag Herbals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 03-07-2024
- Paid Up Capital ₹ 2.09 M
as on 03-07-2024
- Company Age 24 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.00 Cr
as on 03-07-2024
- Revenue 57.06%
(FY 2023)
- Profit 141.70%
(FY 2023)
- Ebitda 96.96%
(FY 2023)
- Net Worth 103.54%
(FY 2023)
- Total Assets 70.35%
(FY 2023)
About Indfrag Herbals
The Corporate was formerly known as Sushrut Herbals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.09 M.
The company currently has active open charges totaling ₹12.00 Cr.
Anita Samuel and Philip Samuel serve as directors at the Company.
- CIN/LLPIN
U24239KA2000PTC026409
- Company No.
026409
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Feb 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Indfrag Herbals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Philip Samuel  | Director | 16-Feb-2000 | Current |
| Anita Samuel | Director | 16-Feb-2000 | Current |
Financial Performance of Indfrag Herbals.
Indfrag Herbals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.06% increase. The company also saw a substantial improvement in profitability, with a 141.7% increase in profit. The company's net worth Soared by an impressive increase of 103.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indfrag Herbals?
In 2023, Indfrag Herbals had a promoter holding of 99.01% and a public holding of 0.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indfrag Bio Sciences Private LimitedActive 9 years 1 monthAnita Samuel and Philip Samuel are mutual person
Stonescape Holdings Private LimitedActive 17 years 6 monthsAnita Samuel and Philip Samuel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Jan 2023 | ₹12.00 Cr | Open |
How Many Employees Work at Indfrag Herbals?
Indfrag Herbals has a workforce of 40 employees as of Apr 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indfrag Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indfrag Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
